It is a pharma private limited company based in Surat, Gujarat, India, established in 2022.
2022 | Surat, Gujarat, India | ActiveOmicron Pharma Private Limited, a active private limited company, was established on 07 June 2022 in Surat, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110GJ2022PTC132698. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.25 M.
Its leadership includes Monikaben Jatinbhai Patel (Director), Hiteshkumar Madhubhai Paneliya (Director), Hemrajbhai Babubhai Anghan (Director). Past directors included Monikaben Jatinbhai Patel. It holds ₹3.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 10-11, Block No. 212, Shiv City Industries-4, Mankana, Tal. Kamrej, Surat, Gujarat, 394325.
U24110GJ2022PTC132698
132698
07 June 2022
₹0.50 M
₹0.25 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Omicron Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monikaben Jatinbhai Patel | Director | 18 Mar 2024 | Current |
| Hiteshkumar Madhubhai Paneliya | Director | 07 Jun 2022 | Current |
| Hemrajbhai Babubhai Anghan | Director | 07 Jun 2022 | Current |
| Abhaykumar Ashokbhai Tandel | Director | 07 Jun 2022 | Current |
| Dharmesh Rameshbhai Kathiriya | Director | 07 Jun 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Omicron Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Omicron Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2022 | Axis Bank Limited | ₹3.60 M | Open |
Explore comprehensive loan charge details -
Omicron Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Omicron Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omicron Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Omicron Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Omicron Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity Monikaben Jatinbhai Patel was appointed as a Director was appointed as a Director on 18 Mar 2024 & has been associated with this company since 1 year 9 months . was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 3.60 M with Charge ID 100657940 was registered on 15 Dec 2022. was completed.
Progress on Hiteshkumar Madhubhai Paneliya was appointed as a Director was appointed as a Director on 07 Jun 2022 & has been associated with this company since 3 years 6 months . was documented.
Hemrajbhai Babubhai Anghan was appointed as a Director was appointed as a Director on 07 Jun 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
The CIN of Omicron Pharma Private Limited is U24110GJ2022PTC132698.
Omicron Pharma Private Limited is headquartered at Plot No. 10-11, Block No. 212, Shiv City Industries-4, Mankana, Tal. Kamrej, Surat, Gujarat, 394325.
Omicron Pharma Private Limited was incorporated on 07 June 2022.
The current directors of Omicron Pharma Private Limited are
The primary industry of Omicron Pharma Private Limited is Manufacturing.
Omicron Pharma Private Limited is unlisted.
The authorized capital of Omicron Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.25 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX